Global Influenza Diagnostics Market 2019-2023

インフルエンザ診断の世界市場2019-2023

◆タイトル:Global Influenza Diagnostics Market 2019-2023
◆商品コード:IRTNTR31642
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年7月20日
◆ページ数:143
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、ヨーロッパ、北米、その他
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査レポートでは、インフルエンザ診断の世界市場について調べ、インフルエンザ診断の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、インフルエンザ診断の市場規模をセグメンテーション別(製品別(ポイントオブケア検査、免疫診断学、分子診断)、)と地域別(アジア、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社はインフルエンザ診断の世界市場規模が2019-2023期間中に年平均6%成長すると予測しています。
・サマリー
・レポートの範囲
・インフルエンザ診断の市場状況
・インフルエンザ診断の市場規模
・インフルエンザ診断の市場予測
・インフルエンザ診断の世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(ポイントオブケア検査、免疫診断学、分子診断)
・インフルエンザ診断の顧客状況
・主要地域別市場規模:アジア、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global Influenza Diagnostics Market: About this market

Influenza diagnostic kits are available in both rapid and conventional testing models. These kits can detect influenza virus strains in swab samples collected from the nasal, nasopharyngeal, or oropharyngeal region. Technavio’s influenza diagnostics market analysis considers sales from point-of-care testing, immunodiagnostics, and molecular diagnostics kits segments to end-user sectors such as hospitals and diagnostic laboratories, academic and research institutions, and home care. Our analysis also considers the sales of influenza diagnostics in Asia, Europe, North America, and ROW. In 2018, the point-of-care testing segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the rising need for rapid influenza testing in outpatient and home care settings and in physician-owned laboratories will significantly help the point-of-care testing segment in maintaining its leading market position. Also, our global Influenza diagnostics report has observed market growth factors such as the increasing demand for point-of-care diagnostics, rising focus on the prevention of pandemic influenza, and high demand for influenza diagnostics during seasonal prevalence. However, challenges such as the lack of laboratory infrastructure in developing regions, consistent development of new diagnostic procedures for emerging influenza virus, and stringent compliance and regulatory requirements may hamper the growth of the Influenza diagnostics industry over the forecast period.

Global Influenza Diagnostics Market: Overview

Increasing demand for point-of-care diagnostics

The rising need for quick influenza monitoring and the lack of healthcare infrastructure in developing countries are increasing the need for point-of-care diagnostics, which provide rapid results. The quick antigen detection ability of rapid influenza diagnostics tests (RIDTs) help healthcare practitioners in providing timely and appropriate treatment. These factors are increasing the sales of RIDT kits, which are point-of-care products. Vendors are further focusing on improving their efficacy and precision. As a result, the market is expected to record a CAGR of almost 6% during the forecast period.

Increasing approvals of influenza diagnostic products by regulatory authorities

Key market vendors have been upgrading their products to meet compliance standards set by authorities such as the US FDA, CFDA, and ECDC. Consequently, the number of approvals is increasing. As a result, many influenza detection kits are commercially available. The sales of these kits will continue to rise owing to the growing incidence of influenza cases across the world, which will augment sales. Therefore, the increasing approvals of influenza diagnostic products by regulatory authorities will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global influenza diagnostics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global influenza diagnostics market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients in improving their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics producers, which include Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc.

Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: SEGMENTATION BY END-USER

PART 07: SEGMENTATION BY INDICATION

PART 08: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Point-of-care testing – Market size and forecast 2018-2023

Immunodiagnostics – Market size and forecast 2018-2023

Molecular diagnostics – Market size and forecast 2018-2023

Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

Surge in number of genetic characterization studies on influenza virus

Increasing approvals of influenza diagnostic products by regulatory authorities

Rising adoption of rapid diagnostic products in physician office laboratories

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Abbott Laboratories

bioMérieux SA

Bio-Rad Laboratories Inc.

Danaher Corp.

Thermo Fisher Scientific Inc.

PART 15: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

Exhibit 01: Years in consideration

Exhibit 02: Global healthcare market

Exhibit 03: Segments of global healthcare market

Exhibit 04: Market characteristics

Exhibit 05: Market characteristics analysis

Exhibit 06: Market segments

Exhibit 07: Market definition – Inclusions and exclusions checklist

Exhibit 08: Market size 2018

Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 11: Five forces analysis 2018

Exhibit 12: Five forces analysis 2023

Exhibit 13: Bargaining power of buyers

Exhibit 14: Bargaining power of suppliers

Exhibit 15: Threat of new entrants

Exhibit 16: Threat of substitutes

Exhibit 17: Threat of rivalry

Exhibit 18: Market condition – Five forces 2018

Exhibit 19: Influenza A diagnostic product in commercial market space:

Exhibit 20: Product – Market share 2018-2023 (%)

Exhibit 21: Comparison by product

Exhibit 22: Point-of-care testing – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Point-of-care testing – Year-over-year growth 2019-2023 (%)

Exhibit 24: Immunodiagnostics – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Immunodiagnostics – Year-over-year growth 2019-2023 (%)

Exhibit 26: Molecular diagnostics – Market size and forecast 2018-2023 ($ millions)

Exhibit 27: Molecular diagnostics – Year-over-year growth 2019-2023 (%)

Exhibit 28: Market opportunity by product

Exhibit 29: Customer landscape

Exhibit 30: Customer landscape analysis

Exhibit 31: Market share by geography 2018-2023 (%)

Exhibit 32: Geographic comparison

Exhibit 33: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: North America – Year-over-year growth 2019-2023 (%)

Exhibit 35: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 41: Key leading countries

Exhibit 42: Market opportunity

Exhibit 43: Decision framework

Exhibit 44: Impact of drivers and challenges

Exhibit 45: Exhibit: Nucleic acid detection-based US FDA-cleared influenza diagnostics test in commercial market (as of 2019)

Exhibit 46: Vendor landscape

Exhibit 47: Landscape disruption

Exhibit 48: Vendor landscape analysis

Exhibit 49: Vendors covered

Exhibit 50: Vendor classification

Exhibit 51: Market positioning of vendors

Exhibit 52: Abbott Laboratories – Vendor overview

Exhibit 53: Abbott Laboratories – Business segments

Exhibit 54: Abbott Laboratories – Organizational developments

Exhibit 55: Abbott Laboratories – Geographic focus

Exhibit 56: Abbott Laboratories – Segment focus

Exhibit 57: Abbott Laboratories – Key offerings

Exhibit 58: bioMérieux SA – Vendor overview

Exhibit 59: bioMérieux SA – Business segments

Exhibit 60: bioMérieux SA – Organizational developments

Exhibit 61: bioMérieux SA – Geographic focus

Exhibit 62: bioMérieux SA – Key offerings

Exhibit 63: Bio-Rad Laboratories Inc. – Vendor overview

Exhibit 64: Bio-Rad Laboratories Inc. – Business segments

Exhibit 65: Bio-Rad Laboratories Inc. – Organizational developments

Exhibit 66: Bio-Rad Laboratories Inc. – Geographic focus

Exhibit 67: Bio-Rad Laboratories Inc. – Segment focus

Exhibit 68: Bio-Rad Laboratories Inc. – Key offerings

Exhibit 69: Danaher Corp. – Vendor overview

Exhibit 70: Danaher Corp. – Business segments

Exhibit 71: Danaher Corp. – Organizational developments

Exhibit 72: Danaher Corp. – Geographic focus

Exhibit 73: Danaher Corp. – Segment focus

Exhibit 74: Danaher Corp. – Key offerings

Exhibit 75: Thermo Fisher Scientific Inc. – Vendor overview

Exhibit 76: Thermo Fisher Scientific Inc. – Business segments

Exhibit 77: Thermo Fisher Scientific Inc. – Organizational developments

Exhibit 78: Thermo Fisher Scientific Inc. – Geographic focus

Exhibit 79: Thermo Fisher Scientific Inc. – Segment focus

Exhibit 80: Thermo Fisher Scientific Inc. – Key offerings

Exhibit 81: Validation techniques employed for market sizing

Exhibit 82: List of abbreviations

Exhibit 83: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc.

★調査レポート[インフルエンザ診断の世界市場2019-2023] (Global Influenza Diagnostics Market 2019-2023 / IRTNTR31642)販売に関する免責事項
[インフルエンザ診断の世界市場2019-2023] (Global Influenza Diagnostics Market 2019-2023 / IRTNTR31642)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆